Increase in the prevalence of infectious diseases and various cancers, rise in demand for personalized medicines, technological advancements in the diagnostic tests, and rise in the preference for biomarker identification tests are anticipated to fuel the molecular diagnostics market. Moreover, rise in geriatric population, increase in healthcare expenditure, developed healthcare infrastructure, and favourable government initiatives for preventing the genetic disorders are also expected to boost the molecular diagnostics market over the forecast period. A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-molecular-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Molecular diagnostics market is segmented on the basis of product type, technology, application, and end user
Based on the product type, molecular diagnostics market is segmented into the following:
• Reagents
• Kits
• Instruments
• Software
Based on technology, molecular diagnostics market is segmented into the following:
• Polymerase chain reaction
• Microarray
• Next generation sequencing
• Isothermal nucleic acid amplification
• Hybridization
• Others
Based on the application, molecular diagnostics market is segmented into the following:
• Caner
• Blood screening
• Infectious diseases
• Microbiology
• Genetic tests
• Others
Based on the end user, molecular diagnostics market is segmented into the following:
• Hospitals
• Diagnostic centres
• Research institutes
• Others
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-molecular-diagnostics-market/#ulp-c654SbFYO64MsOhu[/URL]
Molecular diagnostics market is in the developing stage owing to increase in the prevalence of cancer, infectious disease such as HIV (according to World Health Organisation, global health observatory (GHO) data, in 2013, approximately 34-38 million people suffered from HIV infection worldwide), and hepatitis among others. Rise in research activities for the prevention of genetic disorders also fuels the molecular diagnostics market. Acquisitions & mergers, collaborations, and innovation of novel diagnostic methods are some key strategies followed by companies for increasing their revenue in the molecular diagnostics market. For instance, in August 2015, Roche Diagnostics has acquired GeneWeave Biosciences, Inc. for strengthening its portfolio in microbiology diagnostics. Moreover, in April 2015, Alere Inc. received FDA approval for Alere I Strep, a molecular diagnostic test for the detection of Group A Streptococcus bacteria.
Some of the players in molecular diagnostics market are Cepheid Inc. (Danaher Corporation) (U.S.), Biomerieux (Sofiana s.a.) (France), Beckman Coulter, Inc. (Danaher Corporation) (U.S.), Becton, Dickinson and Company (U.S.), Siemens Healthcare GmbH (Germany), Abbott Laboratories (U.S.), Grifols (Spain), Hologic, Inc. (U.S.), Qiagen (U.S.), Alere Inc. (U.S.), Roche Diagnostics (U.S.), and DiaSorin S.p.A. (American Standard Companies) (Italy) to name a few.
Get access to full summary @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-molecular-diagnostics-market/[/URL]
Email: sales@precisionbusinessinsights.com
Toll Free(US): +1-866-598-1553